Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia

Archives of Internal Medicine

Volumn 170, Issue 4, 2010, Pages 347-353

  Eber, Michael R ^a   Laxminarayan, Ramanan ^a,b   Perencevich, Eli N ^c   Malani, Anup ^d  

^a Center for Disease Dynamics Economics and Policy   (United States)

^b PRINCETON UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CHICAGO LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ELECTIVE SURGERY; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SEPSIS; CROSS INFECTION; ECONOMICS; FACTUAL DATABASE; HOSPITALIZATION; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

CROSS INFECTION; DATABASES, FACTUAL; HEALTH CARE COSTS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; UNITED STATES;

EID: 77949910338     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.509     Document Type: Article

References (41)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-166.
2. Leape LL, Berwick DM. Five years after To Err Is Human: what have we learned? JAMA. 2005;293(19):2384-2390. (Pubitemid 40676761)
3. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271(20):1598-1601. (Pubitemid 24987508)
4. Graves N, Weinhold D, Tong E, et al. Effect of healthcare-acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007;28(3):280-292. (Pubitemid 46480726)
5. Schulgen G, Kropec A, Kappstein I, Daschner F, Schumacher M. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol. 2000;53(4):409-417.
6. Bates DW, Yu DT, Black E, et al; AMCC Sepsis Syndrome Working Group, Academic Medical Center Consortium. Resource utilization among patients with sepsis syndrome. Infect Control Hosp Epidemiol. 2003;24(1):62-70.
7. Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg. 2006;243(4):547-552.
8. Cosgrove SE, Perencevich EN. Economic evaluation of healthcare-associated infections and infection control interventions. In: Jarvis WR, ed. Bennet and Brachman's Hospital Infections. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:235-246.
9. Byers KE, Farr BM. The impact of catheter-related bloodstream infections. In: O'Grady NP, Pittet D, eds. Catheter-Related Infections in the Critically Ill. New York, NY: Springer; 2004:87-98.
10. Yu DT, Black E, Sands KE, et al; Academic Medical Center Consortium Sepsis Project Working Group. Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care. 2003;7(3):R24-R34.
11. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290(14):1868-1874.
12. Noskin GA, Rubin RJ, Schentag JJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med. 2005;165(15):1756-1761.
13. Sherman ER, Heydon KH, St John KH, et al. Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol. 2006;27(4):332-337.
14. Stevenson KB, Khan Y, Dickman J, et al. Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control. 2008;36(3):155-164.
15. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546-1554.
16. Aronsky D, Haug PJ, Lagor C, Dean NC. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual. 2005;20(6):319-328.
17. Bochud PY, Glauser M, Calandra T; International Sepsis Forum. Antibiotics in sepsis. Intensive Care Med. 2001;27(14)(suppl 1):S33-S48.
18. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-1310.
19. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med. 2002;346(22):1715-1722.
20. Iezzoni LI. Complications Screening Program for the Health Care Financing Administration (CSP-HCFA): CSP Updated to FY 1993 Coding Guidelines. Boston, MA: Beth Israel Hospital; 1994.
21. Overview of the Nationwide Inpatient Sample (NIS). http://www.hcup-us. ahrq.gov/nisoverview.jsp. Accessed February 17, 2009.
22. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: US Dept of Health and Human Services; 1988.
23. Agency for Healthcare Research and Quality. HCUP Cost-to-Charge Ratio Files (CCR): Healthcare Cost and Utilization Project, 2001-2003. http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. Accessed February 17, 2009.
24. US Department of Health and Human Services. Official ICD-9-CM Guidelines for Coding and Reporting. Hyattsville, MD: National Center for Health Statistics; 2008.
25. Agency for Healthcare Research and Quality. AHRQ Quality Indicators - Patient Safety Indicators: Technical Specifications. Rockville, MD: Agency for Health-care Research and Quality; 2009.
26. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301(20):2120-2128.
27. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) Manual: Patient Safety Component Protocol. Atlanta, GA: Division of Healthcare Quality Promotion, National Center for Infectious Diseases; 2008.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
29. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139.
30. González C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29(5):1171-1177. (Pubitemid 30265635)
31. Foglia EE, Fraser VJ, Elward AM. Effect of nosocomial infections due to antibioticresistant organisms on length of stay and mortality in the pediatric intensive care unit. Infect Control Hosp Epidemiol. 2007;28(3):299-306.
32. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128(6):3854-3862. (Pubitemid 43062645)
33. Kellum JA, Kong L, Fink MP, et al; GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655-1663. (Pubitemid 47280347)
34. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-1256.
35. Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE; Society for Healthcare Epidemiology of America. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28(10):1121-1133.
36. HHS efforts to reduce healthcare-associated infections. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/ncidod/dhqp/hicpac/ HHS presentationHICPAC-11-08.pdf. Accessed March 16, 2009.
37. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9(2):196-203. (Pubitemid 36231790)
38. Haley RW, White JW, Culver DH, Hughes JM. The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system: an empirical determination from a nationally representative sample. JAMA. 1987; 257(12):1611-1614.
39. Dimick JB, Weeks WB, Karia RJ, Das S, Campbell DA Jr. Who pays for poor surgical quality? building a business case for quality improvement. J Am Coll Surg. 2006;202(6):933-937. (Pubitemid 43776450)
40. Roberts RR, Frutos PW, Ciavarella GG, et al. Distribution of variable vs fixed costs of hospital care. JAMA. 1999;281(7):644-649. (Pubitemid 29098066)
41. Graves N, McGowan JE Jr. Nosocomial infection, the Deficit Reduction Act, and incentives for hospitals. JAMA. 2008;300(13):1577-1579.